Presentation is loading. Please wait.

Presentation is loading. Please wait.

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Published byCharlene Wilson Modified over 5 years ago

Similar presentations

Presentation on theme: "Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,"— Presentation transcript:

1 Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine, MD, D. Desaulniers, MD, J. Perron, MD, R. Baillot, MD, G. Raymond, MD, J. Métras, MD, D. Doyle, MD, P. Mathieu, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 129, Issue 5, Pages (May 2005) DOI: /j.jtcvs Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Freedom from all death.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Freedom from cardiac death.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Freedom from reoperation.
The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2005 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement?  F. Dagenais, MD, P. Cartier, MD, P. Voisine,"

Similar presentations

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Challenging homografts as the holy grail for aortic valve endocarditis

Challenging homografts as the holy grail for aortic valve endocarditis
When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 

When is the Ross operation a good option to treat aortic valve disease?  Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc 
Intrinsic cardiac stem cells are essential for regeneration

Intrinsic cardiac stem cells are essential for regeneration
Abracadabra I, II…HeartMate 3?

Abracadabra I, II…HeartMate 3?
Form ever follows function

Form ever follows function
Bicuspid aortic valve aortopathy: One size fits all?

Bicuspid aortic valve aortopathy: One size fits all?
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 

Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 

The lord of the rings  Antonio Miceli, MD, PhD 
The variability of the mitral valve anatomy and terminology

The variability of the mitral valve anatomy and terminology
Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement  Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,
Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 

Juan N. Pulido, MD  The Journal of Thoracic and Cardiovascular Surgery 
Transcatheter aortic valve replacement in intermediate-risk patients

Transcatheter aortic valve replacement in intermediate-risk patients
Innovation and science: The future of valve design

Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.

Similar presentations

Ads by Google